Stabilin-1+/SMA- macrophages in diagnostics of postinfarction tissue inflammation associated with adverse cardiac remodeling in patients with myocardial infarction

被引：0

作者：

Gombozhapova, A. ^{[1
]}

Rogovskaya, Y. ^{[1
]}

Rebenkova, M. ^{[1
]}

Kzhyshkowska, J. ^{[2
]}

Ryabov, V ^{[1
]}

机构：

[1] Tomsk NRMC, Cardiol Res Inst, Tomsk, Russia

[2] Natl Res Tomsk State Univ, Tomsk, Russia

来源：

EUROPEAN HEART JOURNAL | 2020年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：917 / 917

页数：1

共 50 条

[31] Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction
Zhang, Fuyang
Xia, Yunlong
Yan, Wenjuan
Zhang, Haoqiang
Zhou, Fen
Zhao, Shihao
Wang, Wei
Zhu, Di
Xin, Chao
Lee, Yan
Zhang, Ling
He, Yuan
Gao, Erhe
Tao, Ling
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 310 (02): : H250 - H261
[32] Sustained myocardial production of stromal cell-derived factor-1α was associated with left ventricular adverse remodeling in patients with myocardial infarction
Uematsu, Manabu
Yoshizaki, Toru
Shimizu, Takuya
Obata, Jun-ei
Nakamura, Takamitsu
Fujioka, Daisuke
Watanabe, Kazuhiro
Watanabe, Yosuke
Kugiyama, Kiyotaka
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (10): : H1764 - H1771
[33] Azithromycin Therapy Reduces Cardiac Inflammation and Mitigates Adverse Cardiac Remodeling After Myocardial Infarction: Potential Therapeutic Strategy in Ischemic Heart Disease
Al-Darraji, Ahmed
Haydar, Dalia
Chelvarajan, Lakshman
Tripathi, Himi
Levitan, Bryana
Ahmed, Ahmed E.
Ye, Shaojing
Feola, David
Abdel-Latif, Ahmed
CIRCULATION, 2017, 136
[34] Autotaxin Inhibition Reduces Cardiac Inflammation and Mitigates Adverse Cardiac Remodeling After Myocardial Infarction: Potential Therapeutic Targets for Ischemic Heart Disease
Tripathi, Himi
Chelvarajan, Lakshman
Al-Darraji, Ahmed
Ye, Shaojing
Levitan, Bryana
Brandon, J. Anthony
Morris, Andrew J.
Smyth, Susan S.
Abdel-Latif, Ahmed
CIRCULATION, 2017, 136
[35] Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease
Al-Darraji, Ahmed
Haydar, Dalia
Chelvarajan, Lakshman
Tripathi, Himi
Levitan, Bryana
Gao, Erhe
Venditto, Vincent J.
Gensel, John C.
Feola, David J.
Abdel-Latif, Ahmed
PLOS ONE, 2018, 13 (07):
[36] Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction
Spinale, Francis G.
Mukherjee, Rupak
Zavadzkas, Juozas A.
Koval, Christine N.
Bouges, Shenikqua
Stroud, Robert E.
Dobrucki, Lawrence W.
Sinusas, Albert J.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (39) : 30316 - 30327
[37] Cardamonin protects against adverse cardiac remodeling through mTORC1 inhibition in mice with myocardial infarction
You, Wei
Wu, Zhiming
Ye, Fei
Wu, Xiangqi
PHARMAZIE, 2018, 73 (09): : 508 - 512
[38] Overexpression of TIMP-1 in Embryonic Stem Cells Attenuates Adverse Cardiac Remodeling Following Myocardial Infarction
Glass, Carley
Singla, Dinender K.
CELL TRANSPLANTATION, 2012, 21 (09) : 1931 - 1944
[39] Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction (vol 20, pg 29, 2018)
Dick, Sarah A.
Macklin, Jillian A.
Nejat, Sara
Momen, Abdul
Clemente-Casares, Xavier
Althagafi, Marwan G.
Chen, Jinmiao
Kantores, Crystal
Hosseinzadeh, Siyavash
Aronoff, Laura
Wong, Anthony
Zaman, Rysa
Barbu, Iulia
Besla, Rickvinder
Lavine, Kory J.
Razani, Babak
Ginhoux, Florent
Husain, Mansoor
Cybulsky, Myron I.
Robbins, Clinton S.
Epelman, Slava
NATURE IMMUNOLOGY, 2019, 20 (05) : 664 - 664
[40] Paeoniflorin Improves Cardiac Function and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Rat Model of Acute Myocardial Infarction (vol 12, pg 823, 2018)
Chen, H.
Dong, Y.
He, X.
Li, J.
Wang, J.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5043 - 5043

← 1 2 3 4 5 →